Combination Therapy for Childhood HCV - Safety (Phase 1)

• Types of AEs observed similar to those seen in adults

• 2 of the 61 patients (3%) discontinued due to AEs

• 7 of the 61 patients (11%) required dose modification due to AEs

Previous slide

Next slide

Back to first slide

View graphic version